News | News By Subject | News by Disease News By Date | Search News

HIV/AIDS News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Theratechnologies (TH.TO) Says 82.5% of Patients Achieved Primary Endpoint in Phase III Ibalizumab Trial     5/24/2016
FDA Approves Gilead (GILD)'s Next-Generation HIV Drug Descovy     4/5/2016
FDA Green Lights Gilead (GILD)’s Odefsey to Treat HIV-1 Infection in Certain Patients     3/2/2016
GlaxoSmithKline (GSK) Does Late Holiday Shopping, Buys Two HIV Asset Programs from Bristol-Myers Squibb (BMY) For Up to $2 Billion     12/18/2015
ViiV Healthcare Hitting Hard But Gilead (GILD) Management is Well-Prepared     11/4/2015
Imprimis (immy) Offers $1 Alternative to Turing Pharma's $750 AIDS Drug     10/23/2015
Gilead (GILD)'s New HIV Drug Genvoya Shows Lower Side-Effects Over Longer Term in Two Late-Stage Studies     10/22/2015
Turing Pharma Not Justified in Increasing Daraprim Price by 5,000 Percent, BioSpace Readers Say     9/25/2015
Turing Pharma Becomes Political Football, Donald Trump Weighs In     9/25/2015
Outcry Forces Turing Pharma to Reduce Price Increase of Toxoplasmosis Drug     9/24/2015
GlaxoSmithKline (GSK)'s ViiV Healthcare Successful But Heat From Gilead (GILD) May Be Its Downfall     7/9/2015
Johnson & Johnson (JNJ) HIV Vaccine Blocks Virus in 50% of Monkeys, Soon to Start Human Trial in 400     7/9/2015
EXCLUSIVE: Cancer Therapy Benefits Realized Long After FDA Approval, Study Author Tells BioSpace (DHX)     6/29/2015
Exciting Time for Biotech in New Jersey     6/29/2015
GlaxoSmithKline (GSK), University of North Carolina Set Up $20 Million Spinoff to Find a Cure for HIV/AIDS     5/12/2015

News from Around the Web
Startup Targets HIV Drug Resistance In Developing Countries, Aldatu Biosciences Reveals     6/16/2016
In Pursuit Of An HIV Vaccine And The AIDS-Free Generation     5/17/2016
First Liver Transplant Between HIV-Positive Donor And Recipient Marks Milestone For HIV Patients, Johns Hopkins University Reveals     3/31/2016
Scientists Eliminate HIV-1 From DNA Of Human T-Cells, Temple University Reveals     3/24/2016
Stanford University Chemists Develop An Ultra-Sensitive Test For Cancers, HIV     3/21/2016
Ultra-Sensitive Test Developed For Cancers, HIV, Stanford University Chemists Reveal     3/11/2016
Hospital Warns 213 Patients May Have Been Exposed To Hepatitis, HIV Due To Tampering of Drugs By Ex-Employee     2/26/2016
Investors Aren't Impressed as Charlie Sheen Reveals He Wants in on Tiny CytoDyn (CYDY)'s HIV Drug Trial     2/12/2016
Nixing Latex: Building The Perfect Condom With Hydrogel, Plant-Based Antioxidants, Texas A&M University Study     12/1/2015
Charlie Sheen Has HIV. Five Things You Might Not Know About The Virus     11/18/2015
Daily Pills Protect People Against HIV, Whitman-Walker Clinic Study Finds     11/17/2015
Powerful Plastic Microscope Brings Better Diagnostic Care For World's Rural Poor, Rice University Reveals     10/21/2015
Fat-Coated Drugs Keep Immune Cells Free Of HIV, University of Rochester Study     10/20/2015
Science Won't Stop Until It Beats AIDS, Says HIV Pioneer     10/9/2015
Detecting HIV Diagnostic Antibodies With DNA Nanomachines, University Of Montreal Study     10/9/2015

Press Releases
European Commission (EC) Grants Marketing Authorization For Gilead (GILD)’s Single Tablet Regimen Odefsey (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) For The Treatment Of HIV     6/23/2016
ASM Microbe 2016 Presentation of Clinical Results From CytoDyn (CYDY)’s Phase IIb Monotherapy Extension Study Now Available     6/22/2016
Kowa Pharmaceuticals America Release: New Data Demonstrate Pitavastatin More Effective Than Pravastatin In Improving Inflammatory And Immune Activation Markers In HIV-Infected Patients     6/21/2016
Gilead (GILD) Presents Preliminary Data On Bictegravir, An Investigational Integrase Strand Transfer Inhibitor For The Treatment Of HIV     6/20/2016
CytoDyn (CYDY)n’s PRO 140 Phase IIb HIV Monotherapy Trial Findings To Be Presented At ASM Microbe 2016 Conference On June 20     6/17/2016
City of Hope Release: Autologous Stem Cell Transplantation Offers Safe And Effective, And Potentially Curative, Option For Patients With HIV-Associated Lymphoma     6/14/2016
ViiV Healthcare Announces FDA Approval To Lower The Weight Limit For Dolutegravir In Children And Adolescents Living With HIV     6/10/2016
Istituto Superiore di Sanita Release: Improving The Effect Of HIV Drugs By Use Of The Tat Vaccine     6/8/2016
Immunocore’s Immtav Shown To Redirect The Immune System To Kill HIV-Infected Cells From Patients Treated With Antiretroviral Therapy     6/8/2016
Frontier Biotech's Long-Acting HIV-1 Fusion Inhibitor Albuvirtide Meets 48-Week Primary Objective: Interim Results Of A Phase 3 Trial     6/6/2016
amfAR Research Funding Targets Biggest Roadblocks To HIV Cure     6/3/2016
Ongoing Clinical Development Of ABX464: ABIVAX Launches ABX464-004 Study     5/31/2016
International AIDS Vaccine Initiative Release: New HIV-Mimicking Particles That Trigger Immune Response Could Advance Aids Vaccine Design     5/20/2016
Mologen AG (MOLGF.PK): Further Progress In Clinical Studies With Lead Product Lefitolimod In Q1 2016     5/12/2016
Viriom Announces Receipt Of Funding From The Skolkovo Foundation, ChemRar And Torrey Pines Investment To Develop Elpida, A Novel Preventive And Long-Acting Treatment Of HIV/AIDS     5/11/2016

//-->